Back to results
US 2019/0169307 A1Published application
Glycoprotein v inhibitors for use as coagulants
AssigneeJulius-Maximilians-UniversitäT WüRzburg
InventorsBernhard NIESWANDT, Sarah BECK, David STEGNER
Life of this patent
Estimating the term…
Abstract
The present invention relates to an inhibitor of platelet glycoprotein V (GPV) for use as a coagulant, and/or for use in the treatment or prevention of a hemorrhagic condition.
Claims21
(canceled)
A method for the treatment or prevention of a hemorrhagic condition comprising administering to a subject in need thereof an effective amount of an inhibitor of platelet glycoprotein V (GPV).
A pharmaceutical composition comprising an inhibitor of platelet glycoprotein V (GPV) and a pharmaceutically acceptable excipient.
(canceled)
Dependencies are inferred from the claim text.